[1] Xie D,Ren Z,Fan J,et al.Genetic profiling of intrahepatic cholangiocarcinoma and its clinical implication in targeted therapy. Am J Cancer Res,2016,6(3):577-586. [2] Kaira K,Sunose Y,Ohshima Y,et al.Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer. BMC Cancer,2013,13(1):5123-5128. [3] Ercan C,Diest PJV,Ende BVD,et al.p53 mutations in classic and pleomorphic invasive lobular carcinoma of the breast. Cell Oncol,2012,35(2):111-118. [4] Merikallio H,Paakko P,Harju T,et al.Claudins 10 and 18 are predominantly expressed in lung adenocarcinomas and in tumors of nonsmokers. Int J ClinExperiment Pathol,2011,4(7):667-673. [5] Lee DY,Park CS,Kim HS,et al.Maspin and p53 protein expression in gastric adenocarcinoma and its clinical applications. App Immunohistochem Mol Morphol Aimm,2008,16(1):13-18. [6] Hsu M.KRAS and GNAS mutations and p53 overexpression in biliary intraepithelial neoplasia and intrahepatic cholangiocarcinomas. Cancer,2013,119(9):1669-1674. [7] Keira Y,Takasawa A,Murata M,et al.An immunohistochemical marker panel including claudin-18,maspin,and p53 improves diagnostic accuracy of bile duct neoplasms in surgical and presurgical biopsy specimens. Archiv Für Pathologische Anatomie Und Physiologie Und Für Klinische Medicin,2015,466(3):265-277. [8] 刘英杰,桂淑玉,周青,等. Claudin-18 蛋白在肺腺癌所致恶性胸腔积液中的表达及临床意义. 安徽医科大学学报,2014,49(12):1788-1791. [9] Soini Y,Takasawa A,Eskelinen M,et al.Expression of claudins 7 and 18 in pancreatic ductal adenocarcinoma:association with features of differentiation. J Clin Pathol,2012,65(5):431-436. [10] Rho SY,Bae SU,Baek SJ,et al.Feasibility and safety of laparoscopic resection following stent insertion for obstructing left-sided colon cancer. J Kor Surg Soc,2013,85(6):290-295. [11] Webber BA,Lawson D,Cohen C.Maspin and Mutant p53 expression in malignant melanoma and carcinoma:use of tissue microarray. AppImmunohistochem Mol Morphol Aimm,2008,16(1):19-23. [12] Payne CM,Holubec H,Crowley-Skillicorn C,et al.Maspin is a deoxycholate-inducible,anti-apoptotic stress-response protein differentially expressed during colon carcinogenesis. Clin Exp Gastroenterol,2011,4(1):239-253. [13] Prica F,Radon T,Cheng Y,et al.The life and works of S100P-from conception to cancer. Am J Cancer Res,2016,6(2):562-576. [14] Secord AA,Darcy KM,Hutson A,et al.The regulation of MASPIN expression in epithelial ovarian cancer:Association with p53 status,and MASPIN promoter methylation:A Gynecologic Oncology Group study. Gynecol Oncol,2011,123(2):314-319. [15] Santer FR,Malinowska K,Culig Z,et al.Interleukin-6 trans-signalling differentially regulates proliferation,migration,adhesion and maspin expression in human prostate cancer cells. Endocr Relat Cancer,2010,17(1):241-253. [16] Yanagisawa N,Hana K,Nakada N,et al.High expression of L-type amino acid transporter 1 as a prognostic marker in bile duct adenocarcinomas. Cancer Med,2014,3(5):1246-1255. [17] Joerger AC,Fersht AR.The tumor suppressor p53:from structures to drug discovery. Cold Spring Harbor Perspect Biol,2010,2(6):968-976. [18] Glanzer JG,Carnes KA,Soto P,et al.A small molecule directly inhibits the p53 transactivation domain from binding to replication protein A. Nucl Acids Res,2013,41(3):2047-2059. [19] 戚峰,邰升,苏志雷. p33ING1b与p53在胆管癌中的表达及临床意义. 中国现代普通外科进展,2015,18(7):509-512. [20] Shinozaki A,Shibahara J,Noda N,et al.Claudin-18 in biliary neoplasms. Its significance in the classification of intrahepatic cholangiocarcinoma. Virchows Archiv,2011,459(1):73-80. |